03/10/2026
Great lecture by WIN SYMPOSIUM 2026 led by Wafik El-Deiry and Dr Rochelle Kurzrock
Where screening is organized, fewer cancers end in death.
GLOBOCAN 2024: deaths per new case are far lower where programs actually reach people.
Breast mortality-to-incidence: Korea 14% · Japan 18% · Sweden 19% · US 16% vs Romania 29% · Peru 28% · Vietnam 41% · Indonesia 41% · Nigeria 48%
Low-screening nations: 2.3× higher breast-cancer mortality per case (37.5% vs 16.5%). Across 194 countries, regular screening in women 50–74 cut that ratio from 0.56 to 0.30.
Participation still varies fourfold: UK 85.5%, Korea 56.7%, UAE 25%, China 22.3%. Paying for it is not the same as people showing up. Cities screen; rural areas do not.
Universal screening is unaffordable. Risk-based national strategy is not optional.